Jundishapur Journal of Microbiology

Published by: Kowsar

Multidrug-Resistant Escherichia coli and Klebsiella pneumoniae Isolated From Patients in Kashan, Iran

Atieh Sadat Moini 1 , Babak Soltani 1 , * , Abbas Taghavi Ardakani 1 , Alireza Moravveji 2 , Mahzad Erami 3 , Mostafa Haji Rezaei 4 and Mansoor Namazi 4
Authors Information
1 Department of Pediatrics, Kashan University of Medical Sciences, Kashan, IR Iran
2 Department of Community Medicine, Trauma Research Center, Kashan University of Medical Sciences, Kashan, IR Iran
3 Department of Microbiology, Kashan University of Medical Sciences, Kashan, IR Iran
4 Trauma Research Center, Kashan University of Medical Sciences, Kashan, IR Iran
Article information
  • Jundishapur Journal of Microbiology: October 01, 2015, 8 (10); e27517
  • Published Online: October 25, 2015
  • Article Type: Research Article
  • Received: January 30, 2015
  • Revised: June 3, 2015
  • Accepted: July 11, 2015
  • DOI: 10.5812/jjm.27517

To Cite: Moini A S, Soltani B, Taghavi Ardakani A, Moravveji A, Erami M, et al. Multidrug-Resistant Escherichia coli and Klebsiella pneumoniae Isolated From Patients in Kashan, Iran, Jundishapur J Microbiol. 2015 ; 8(10):e27517. doi: 10.5812/jjm.27517.

Abstract
Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Ayatollahi J, Vahidi A, Shahcheraghi SH, Bagheripour A, Lotfi M, Lotfi M, et al. Investigating the Resistance of Escherichia coli Against Some Selected Antimicrobials in Bam. Jundishapur J Microbiol. 2013; 6(8)[DOI]
  • 2. Rodriguez-Bano J, Alcala JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, et al. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med. 2008; 168(17): 1897-902[DOI][PubMed]
  • 3. Dormanesh B, Safarpoor Dehkordi F, Hosseini S, Momtaz H, Mirnejad R, Hoseini MJ, et al. Virulence factors and o-serogroups profiles of uropathogenic Escherichia coli isolated from Iranian pediatric patients. Iran Red Crescent Med J. 2014; 16(2)[DOI][PubMed]
  • 4. Centers for Disease C. Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep. 2013; 62(9): 165-70[PubMed]
  • 5. Allocati N, Masulli M, Alexeyev MF, Di Ilio C. Escherichia coli in Europe: an overview. Int J Environ Res Public Health. 2013; 10(12): 6235-54[DOI][PubMed]
  • 6. Russo T. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect. 2003; 5(5): 449-56[DOI]
  • 7. Heidary M, Momtaz H, Madani M. Characterization of Diarrheagenic Antimicrobial Resistant Escherichia coli Isolated From Pediatric Patients in Tehran, Iran. Iran Red Crescent Med J. 2014; 16(4)[DOI][PubMed]
  • 8. Mantzarlis K, Makris D, Manoulakas E, Karvouniaris M, Zakynthinos E. Risk Factors for the First Episode of Klebsiella pneumoniae Resistant to Carbapenems Infection in Critically Ill Patients: A Prospective Study. BioMed Res Int. 2013: 1-8[DOI]
  • 9. Tang SS, Apisarnthanarak A, Hsu LY. Mechanisms of beta-lactam antimicrobial resistance and epidemiology of major community- and healthcare-associated multidrug-resistant bacteria. Adv Drug Deliv Rev. 2014; 78: 3-13[DOI][PubMed]
  • 10. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012; 18(3): 268-81[DOI][PubMed]
  • 11. Tsukamoto N, Ohkoshi Y, Okubo T, Sato T, Kuwahara O, Fujii N, et al. High prevalence of cross-resistance to aminoglycosides in fluoroquinolone-resistant Escherichia coli clinical isolates. Chemotherapy. 2013; 59(5): 379-84[DOI][PubMed]
  • 12. Vernaz N, Huttner B, Muscionico D, Salomon JL, Bonnabry P, Lopez-Lozano JM, et al. Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community. J Antimicrob Chemother. 2011; 66(4): 928-35[DOI][PubMed]
  • 13. Mohamed Ali MM, Alemary F, Alrtail A, Rzeg MM, Albakush AM, Ghenghesh KS. High isolation rates of multidrug-resistant bacteria from water and carpets of mosques. Libyan J Med. 2014; 9[DOI]
  • 14. Forbes BA, Sahm DF, Weissfeld AS. Bailey & Scott's Diagnostic Microbiology. 2007;
  • 15. 17th Informational Supplement. 2007;
  • 16. Rezaee MA, Sheikhalizadeh V, Hasani A. Detection of integrons among multi-drug resistant (MDR) Escherichia coli strains isolated from clinical specimens in northern west of Iran. Braz J Microbiol. 2011; 42(4): 1308-13[DOI][PubMed]
  • 17. Shams F, Hasani A, Pormohammad A, Rezaee MA, Reza M, Nahaie AH. A implicated quinolone resistance in Escherichia coli and Klebsiella pneumoniae clinical isolates from a University Teaching Hospital. Life Sci J. 2014; 11(12)
  • 18. Salem MM, Muharram M, Alhosiny IM. Distribution of classes 1 and 2 integrons among multi drug resistant E. coli isolated from hospitalized patients with urinary tract infection in Cairo, Egypt. Aust J Basic Appl Sci. 2010; 4(3): 398-407
  • 19. Kibret M, Abera B. Antimicrobial susceptibility patterns of E. coli from clinical sources in northeast Ethiopia. Afr Health Sci. 2011; 11 Suppl 1-5[PubMed]
  • 20. Ibrahim ME, Bilal NE, Hamid ME. Increased multi-drug resistant Escherichia coli from hospitals in Khartoum state, Sudan. Afr Health Sci. 2012; 12(3): 368-75[PubMed]
  • 21. Ngwai YB, Akpotu MO, Obidake RE, Sounyo AA, Onanuga A, Origbo SO. Antimicrobial susceptibility of Escherichia coli and other coliforms isolated from urine of asymptomatic students in Bayelsa State, Nigeria. Afr J Microbiol Res. 2010; 5(3): 184-91
  • 22. Ullah F, Malik SA, Ahmed J. Antimicrobial susceptibility pattern and ESBL prevalence in Klebsiella pneumoniae from urinary tract infections in the North-West of Pakistan. Afr J Microbiol Res. 2009; 3(11): 676-80
  • 23. Lina TT, Rahman SR, Gomes DJ. Multiple-antibiotic resistance mediated by plasmids and integrons in uropathogenic Escherichia coli and Klebsiella pneumoniae. Bangladesh J Microbiol. 2007; 24(1): 19-23
  • 24. Subha A, Ananthan S, Alavandi SV. Extended spectrum beta lactamase production & multidrug resistance in Klebsiella species isolated from children under five with intestinal & extraintestinal infections. Indian J Med Res. 2001; 113: 181-5[PubMed]
  • 25. Oteo J, Lazaro E, de Abajo FJ, Baquero F, Campos J, Spanish members of E. Antimicrobial-resistant invasive Escherichia coli, Spain. Emerg Infect Dis. 2005; 11(4): 546-53[DOI][PubMed]
  • 26. Sahm DF, Thornsberry C, Mayfield DC, Jones ME, Karlowsky JA. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob Agents Chemother. 2001; 45(5): 1402-6[DOI][PubMed]
  • 27. Serefhanoglu K, Turan H, Timurkaynak FE, Arslan H. Bloodstream infections caused by ESBL-producing E. coli and K. pneumoniae: risk factors for multidrug-resistance. Braz J Infect Dis. 2009; 13(6): 403-7[PubMed]
  • 28. Park SY, Kang CI, Joo EJ, Ha YE, Wi YM, Chung DR, et al. Risk factors for multidrug resistance in nosocomial bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Microb Drug Resist. 2012; 18(5): 518-24[DOI][PubMed]
  • 29. Ahmed MO, Williams NJ, Clegg PD, van Velkinburgh JC, Baptiste KE, Bennett M. Analysis of risk factors associated with antibiotic-resistant Escherichia coli. Microb Drug Resist. 2012; 18(2): 161-8[DOI][PubMed]
  • 30. Aliberti S, Di Pasquale M, Zanaboni AM, Cosentini R, Brambilla AM, Seghezzi S, et al. Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis. 2012; 54(4): 470-8[DOI][PubMed]
  • 31. Clark NM, Patterson J, Lynch J3. Antimicrobial resistance among gram-negative organisms in the intensive care unit. Curr Opin Crit Care. 2003; 9(5): 413-23[PubMed]
  • 32. O’Fallon E, Kandell R, Schreiber R, D’Agata E. Acquisition of Multidrug‐Resistant Gram‐Negative Bacteria: Incidence and Risk Factors within a Long‐Term Care Population. Infect Control Hospital Epidemiol. 2010; 31(11): 1148-53[DOI]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments